ArH); 13C NMR δ 12.9, 16.3, 17.9, 20.5, 30.7, 60.0, 60.4, 126.4,
128.5, 135.7, 142.5, 170.3; HRMS m/z 322.1090 (M + Na)+,
calc. for C14H21NO4SNa 322.1090; m/z (EI) 226 (100%), 155
(64), 91 (64).
J = 7.6 Hz, 1H, CH), 6.30–7.35 (m, 9H, ArH); 13C NMR δ 8.9,
9.0, 11.9, 26.3, 58.9, 111.2, 112.0, 119.6, 121.4, 127.4, 128.1,
128.6, 137.4, 141.9, 149.8; m/z 265 (EI) (M+, 31%), 236 (100), 91
(34).
2-(4-Tolylsulfonylamino)butyric acid ethyl ester (4c). 1H
NMR δ 0.84 (t, J = 7.6 Hz, 3H, CH3), 1.03 (t, J = 7.2 Hz, 3H,
CH3), 1.56–1.75 (m, 2H, CH2), 2.35 (s, 3H, ArCH3), 3.76 (m,
1H, CH), 3.85 (q, J = 7.2 Hz, 2H, OCH2), 5.08 (d, J = 9.2 Hz,
1H, NH), 7.21 (d, J = 8.4 Hz, 2H, ArH), 7.65 (d, J = 8.4 Hz,
2H, ArH); 13C NMR δ 9.5, 14.2, 21.8, 27.0, 57.0, 61.8, 127.5,
129.8, 136.9, 143.8, 171.9; HRMS m/z 308.0937 (M + Na)+,
calc. for C13H19NO4SNa 308.0933; m/z (EI) 212 (60%), 171 (29),
155 (53), 91 (100).
2-Benzyloxyamino-3,3-dimethylbutyric acid ethyl ester (3j).
1H NMR δ 0.96 (s, 9H, 3 CH3), 1.23 (t, J = 8.4 Hz, 3H, CH3),
3.28 (d, J = 10.3 Hz, 1H, CH), 4.21 (q, J = 8.4 Hz, 2H, OCH2),
4.63 (s, 2H, OCH2), 6.11 (d, J = 10.3 Hz, 1H, NH), 7.25–7.37
(m, 5H, ArH); 13C NMR δ 13.3, 26.0, 32.0, 59.5, 71.0, 74.7,
126.6, 127.1, 127.6, 137.0, 172.9; HRMS m/z 288.1577
(M + Na)+, calc. for C15H23NO3Na 288.1576; m/z (EI) 208
(21%), 192 (36), 91 (100).
3-Benzyloxyamino-4,4-dimethylpentanoic acid ethyl ester
(3k). H NMR δ 0.96 (s, 9H, 3 CH3), 1.22 (t, J = 7.2 Hz, 3H,
1
2-(4-Methoxyphenylamino)-3-methylbutyric acid ethyl ester
(3d). 1H NMR δ 0.95 (d, J = 7.2 Hz, 3H, CH3), 0.97 (d, J = 7.2
Hz, 3H, CH3), 1.18 (t, J = 7.0 Hz, 3H, CH3), 2.01 (octet, J = 7.2
Hz, 1H, CH), 3.65 (s, 3H, OCH3), 3.70 (m, 1H, CH), 3.81 (br,
1H, NH), 4.10 (q, J = 7.0 Hz, 2H, OCH2), 6.55 (d, J = 8.4 Hz,
2H, ArH), 6.70 (d, J = 8.4 Hz, 2H, ArH); 13C NMR δ 14.3, 18.7,
19.1, 31.5, 55.7, 60.7, 63.8, 114.8, 115.3, 141.5, 152.7, 174.0;
HRMS m/z 274.1419 (M + Na)+, calc. for C14H21NO3Na
274.1419; m/z (EI) 251 (M+, 19%), 208 (15), 178 (100), 134 (56),
122 (21). Enantiomers were separated by GC/GC-MS using a
Chrompack chirasil-Dex CB column.
CH3), 2.49 (d, J = 6.0 Hz, 2H, CH2), 3.18 (t, J = 6.0 Hz, 1H,
CH), 4.12 (m, 2H, OCH2), 4.65 (s, 2H, OCH2), 5.80 (br, 1H,
NH), 7.25–7.36 (m, 5H, ArH); 13C NMR δ 14.4, 27.3, 33.8,
34.7, 60.6, 65.9, 76.1, 127.9, 128.5, 128.6, 138.1, 173.7; HRMS
m/z 302.1734 (M + Na)+, calc. for C16H25NO3Na 302.1732; m/z
(EI) 222 (85%), 148 (14), 91 (100).
2-(4-Methoxyphenylamino)-3,3-dimethylbutyric acid ethyl
1
ester (3l). H NMR δ 1.05 (s, 9H, 3 CH3), 1.22 (t, J = 7.2 Hz,
3H, CH3), 3.75 (s, 3H, OCH3), 3.89 (br, 1H, NH), 3.92 (br, 1H,
CH), 4.15 (q, J = 7.2 Hz, 2H, OCH2), 6.63 (d, J = 9.2 Hz, 2H,
ArH), 6.76 (d, J = 9.2 Hz, 2H, ArH); 13C NMR δ 14.3, 26.8,
34.3, 55.7, 60.5, 67.0, 114.8, 115.6, 141.8, 152.7, 173.6; HRMS
m/z 288.1573 (M + Na)+, calc. for C15H23NO3Na 288.1576; m/z
(EI) 265 (M+, 21%), 208 (48), 192 (50), 134 (100).
2-(4-Methoxyphenylamino)butyric acid ethyl ester (4d). 1H
NMR δ 0.92 (t, J = 7.6 Hz, 3H, CH3), 1.18 (t, J = 6.4 Hz, 3H,
CH3), 1.65–1.85 (m, 2H, CH2), 3.65 (s, 3H, OCH3), 3.80 (br, 1H,
NH), 3.86 (m, 1H, CH), 4.11 (q, J = 6.4 Hz, 2H, OCH2), 6.55
(d, J = 6.8 Hz, 2H, ArH), 6.70 (d, J = 6.8 Hz, 2H, ArH); 13C
NMR δ 9.0, 13.3, 25.2, 54.7, 58.0, 59.9, 113.8, 114.1, 140.0,
151.6, 173.3; HRMS m/z 260.1261 (M + Na)+, calc. for
C13H19NO3Na 260.1263; m/z (EI) 237 (M+, 16%), 164 (100), 134
(17), 122 (7).
2-Benzyloxyamino-3-methoxypropionic acid ethyl ester (3m).
1H NMR δ 1.22 (t, J = 7.6 Hz, 3H, CH3), 3.33 (s, 3H, OCH3),
3.59 (d, J = 5.6 Hz, 2H, OCH2), 3.78 (m, 1H, CH), 4.22 (q,
J = 7.6 Hz, 2H, OCH2), 4.73 (s, 2H, OCH2), 6.04 (d, J = 8.4 Hz,
1H, NH), 7.25–7.37 (m, 5H, ArH); 13C NMR δ 14.4, 59.5, 61.5,
64.0, 70.5, 76.6, 128.1, 128.5, 128.6, 137.9, 171.4; HRMS m/z
276.1210 (M + Na)+, calc. for C13H19NO4Na 276.1212; m/z (EI)
208 (10%), 180 (16), 108 (12), 91 (100), 77 (17).
O-Benzyl-N-[1-(2-methoxyphenyl)-2-methylpropyl]hydroxyl-
1
amine (3e). H NMR δ 0.64 (d, J = 6.8 Hz, 3H, CH3), 0.91 (d,
J = 6.8 Hz, 3H, CH3), 1.85–2.05 (octet, J = 6.8 Hz, 1H, CH),
3.72 (s, 3H, OCH3), 3.98 (d, J = 8.0 Hz, 1H, CH), 4.57 (s, 2H,
OCH2), 6.00 (br s, 1H, NH), 6.75–6.91 (m, 2H, ArH), 7.11–7.22
(m, 7H, ArH); 13C NMR δ 20.8, 21.6, 30.5, 57.3, 61.3, 76.1,
110.5, 120.3, 127.4, 127.9, 128.0, 128.2, 128.4, 129.3, 138.0,
157.3; HRMS m/z 308.1629 (M + Na)+, calc. for C18H23NO2Na
308.1626; m/z (EI) 242 (100%), 136 (40), 121 (48), 91 (86), 77
(23).
1
3-Benzyloxyamino-4-methoxybutyric acid ethyl ester (3n). H
NMR δ 1.22 (t, J = 7.2 Hz, 3H, CH3), 2.43 (dd, J = 15.6, 5.6 Hz,
1H, CH), 2.58 (dd, J = 15.6, 5.6 Hz, 1H, CH), 3.35 (s, 3H,
OCH3), 3.42 (d, J = 5.6 Hz, 2H, OCH2), 3.55 (sextet, J = 5.6 Hz,
1H, CH), 4.12 (q, J = 7.2 Hz, 2H, OCH2), 4.70 (s, 2H, OCH2),
6.06 (d, J = 5.6 Hz, 1H, NH), 7.25–7.37 (m, 5H, ArH); 13C
NMR δ 14.4, 34.6, 57.4, 59.3, 60.7, 72.0, 76.8, 128.0, 128.5,
128.6, 138.0, 172.2; HRMS m/z 290.1369 (M + Na)+, calc. for
C14H21NO4Na 290.1368; m/z 222 (42%), 91 (100).
(2-Methoxyphenyl)(2-methyl-1-phenylpropyl)amine (3g). 1H
NMR δ 0.84 (d, J = 6.4 Hz, 3H, CH3), 0.95 (d, J = 6.4 Hz, 3H,
CH3), 2.00 (octet, J = 6.4 Hz, 1H, CH), 3.81 (s, 3H, OCH3), 4.04
(d, J = 5.6 Hz, 1H, CH), 4.71 (br s, 1H, NH), 6.23 (dd, J = 7.6,
1.6 Hz, 1H, ArH), 6.49 (dt, J = 1.6, 7.6 Hz, 1H, ArH), 6.59 (dt,
J =1.6, 7.6 Hz, 1H, ArH), 6.68 (dd, J = 7.6, 1.6 Hz, 1H, ArH),
7.10–7.26 (m, 5H, ArH); 13C NMR δ 18.9, 20.1, 35.2, 55.8, 63.9,
109.4, 110.9, 116.1, 121.4, 126.9, 127.4, 128.4, 137.9, 143.1,
146.9; HRMS m/z 278.1520 (M + Na)+, calc. for C17H21NONa
278.1521; m/z (EI) 255 (M+, 6%), 212 (100), 196 (12), 120 (15),
91 (11).
Acknowledgements
We are indebted to The Danish National Research Foundation
for financial support. Thanks are expressed to Dr Mark
Roberson for performing the theoretical calculations.
References
1 See e.g. (a) D. P. Curran, N. A. Porter and B. Giese, Stereochemistry of
Radical Reactions, VCH, Weinheim, 1995; (b) M. P. Sibi and N. A.
Porter, Acc. Chem. Res., 1999, 32, 163; (c) P. Renaud and M. Gerster,
Angew. Chem., Int. Ed., 1998, 37, 2562.
2 (a) H. Miyabe, C. Ushiro and T. Naito, Chem. Commun., 1997, 1789;
(b) H. Miyabe, R. Shibata, M. Sangawa, C. Ushiro and T. Naito,
Tetrahedron, 1998, 54, 11431; (c) H. Miyabe, H. Tanaka and T. Naito,
Tetrahedron Lett., 1999, 40, 8387; (d) H. Miyabe, K. Fujii and
T. Naito, Org. Lett., 1999, 1, 569; (e) H. Miyabe, C. Konishi and
T. Naito, Org. Lett., 2000, 2, 1443; ( f ) H. Miyabe, C. Ushiro, M.
Ueda, K. Yamakawa and T. Naito, J. Org. Chem., 2000, 65, 176; (g)
H. Miyabe, M. Ueda and T. Naito, J. Org. Chem., 2000, 65, 5043; (h)
H. Miyabe, M. Ueda and T. Naito, Chem. Commun., 2000, 2059.
2-Ethyl-3-(2-methyl-1-phenylpropyl)-2,3-dihydro-1,3,2-benz-
oxazaborole (5a). H NMR δ 0.91 (d, J = 6.8 Hz, 6H, CH3),
1.06–1.27 (m, 5H, CH2CH3), 2.69 (dseptet, J = 11.2, 6.8 Hz, 1H,
CH), 4.30 (d, J = 11.2 Hz, 1H, CH), 6.30–7.35 (m, 9H, ArH);
13C NMR δ 8.9, 9.0, 20.9, 21.6, 30.3, 65.6, 110.6, 112.0, 119.6,
121.4, 127.0, 127.5, 128.7, 138.1, 141.5, 149.5; m/z (EI) 279 (M+,
9%), 236 (100), 91 (11).
1
2-Ethyl-3-(1-phenylpropyl)-2,3-dihydro-1,3,2-benzoxazaborole
1
(5b). H NMR δ 0.87 (t, J = 7.2 Hz, 3H, CH3), 1.06–1.27 (m,
5H, CH2CH3), 2.19 (quintet, J = 7.2 Hz, 2H, CH2), 4.76 (t,
1294
J. Chem. Soc., Perkin Trans. 1, 2001, 1290–1295